The overexpression of ORAI3 in two estrogen receptor-positive (ER+) breast cancer cell lines (MCF-7 and T-47D) decreased the apoptosis induced by several chemotherapeutic agents, including cisplatin, by modulating p53-protein degradation [58]. Here, ORAI3 is linked to breast cancer.